Teevir™ is a licensed generic of Atripla® produced in an FDA approved manufacturing facility in India. It’s a three-drug combination used as a complete treatment regimen for HIV-1. It’s also the current WHO first-line treatment option for HIV-1.
- Teevir™ helps decrease the amount of HIV in your body so your immune system can work better.
- Teevir™ lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life.
- Teevir™ iss indicated in adult and pediatric patients weighing at least 88 pounds (40 kg).